Search

Your search keyword '"Varinder"' showing total 47 results
Start Over Author "Varinder" Journal journal of the american college of cardiology
47 results on '"Varinder"'

1. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

Author

Brothers, Matthew, Marino, Bradley, Canter, Charles, Law, Mark, Nguyen, Nguyenvu, Sang, Charlie, Shimano, Kristin, Gupta, Dipankar, Portman, Michael, Williams, Derek, Glass, Lauren, Sperrazza, Charles, Herold, Steven, Garg, Ruchira, Vranicar, Mark, Awad, Sawsan, Asante-Korang, Alfred, Druzgal, Colleen, Ozment, Caroline, Del Toro, Kamill, Roses, Ferran, Jux, Christian, Gravenhorst, Verena, Schweigmann, Ulrich, Bhatt, Mihir, Sabapathy, Christine, Dahdah, Nagib, Bartonicek, Dototea, Tulzer, Gerald, Basargina, Elena, Zvereva, Tatiana, Pertels, Tatiana, Plotnikova, Irina, Pierre-Emmanuel, S.E.G.U.E.L.A., Amedro, Pascal, Yves, Dulac, BONNET, Damien, Saraco, Paola, Rimini, Alessandro, Digtiar, Valerii, Gonchar, Margaryta, Kryuchko, Tetyana, Yablon, Olga, Bedi, Varinder Singh, Patel, Jashvant, Mitra, Monjori, Kusa, Jacek, Domagala, Kowalczyk, KÖRNYEI, László, BERECZKI, Csaba, ABLONCZY, László, Levitas, Vivianne Aviva, Mishali, David, Revel-Vilk, Shoshana, Harlev, Dan, Sasmaz, Hatice Ilgen, Ozbek, Namik Yasar, Unal, Sule, Patıroglu, Türkan, Malbora, Baris, Agin, Hasan, Karakas, Zeynep, Kavakli, Ramazan Kaan, Chalmers, Elizabeth, Bu'Lock, Frances, Daubeney, Piers, Hamza, Hala, Badr, Mohamed, Elalfy, Mohsen, Mansour, Ahmed, Hassab, Hoda, Sabry, Ayman, Daou, Linda, Bitar, Fadi, Portman, Michael A., Jacobs, Jeffrey P., Newburger, Jane W., Berger, Felix, Grosso, Michael A., Duggal, Anil, Tao, Ben, and Goldenberg, Neil A.

Published
2022
Full Text
View/download PDF

4. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

Author

Michael A. Portman, Jeffrey P. Jacobs, Jane W. Newburger, Felix Berger, Michael A. Grosso, Anil Duggal, Ben Tao, Neil A. Goldenberg, Matthew Brothers, Bradley Marino, Charles Canter, Mark Law, Nguyenvu Nguyen, Charlie Sang, Kristin Shimano, Dipankar Gupta, Michael Portman, Derek Williams, Lauren Glass, Charles Sperrazza, Steven Herold, Ruchira Garg, Mark Vranicar, Sawsan Awad, Alfred Asante-Korang, Colleen Druzgal, Caroline Ozment, Kamill Del Toro, Ferran Roses, Christian Jux, Verena Gravenhorst, Ulrich Schweigmann, Mihir Bhatt, Christine Sabapathy, Nagib Dahdah, Dototea Bartonicek, Gerald Tulzer, Elena Basargina, Tatiana Zvereva, Tatiana Pertels, Irina Plotnikova, S.E.G.U.E.L.A. Pierre-Emmanuel, Pascal Amedro, Dulac Yves, Damien BONNET, Paola Saraco, Alessandro Rimini, Valerii Digtiar, Margaryta Gonchar, Tetyana Kryuchko, Olga Yablon, Varinder Singh Bedi, Jashvant Patel, Monjori Mitra, Jacek Kusa, Kowalczyk Domagala, László KÖRNYEI, Csaba BERECZKI, László ABLONCZY, Vivianne Aviva Levitas, David Mishali, Shoshana Revel-Vilk, Dan Harlev, Hatice Ilgen Sasmaz, Namik Yasar Ozbek, Sule Unal, Türkan Patıroglu, Baris Malbora, Hasan Agin, Zeynep Karakas, Ramazan Kaan Kavakli, Elizabeth Chalmers, Frances Bu'Lock, Piers Daubeney, Hala Hamza, Mohamed Badr, Mohsen Elalfy, Ahmed Mansour, Hoda Hassab, Ayman Sabry, Linda Daou, and Fadi Bitar

Subjects
Heart Diseases, Humans, Anticoagulants, Prospective Studies, Venous Thromboembolism, Child, Cardiology and Cardiovascular Medicine
Abstract

Standard of care (SOC) anticoagulation for thromboembolism (TE) prevention in children with cardiac disease includes low molecular weight heparins or vitamin K antagonists. Limited data exists for alternate use of direct oral anticoagulants in children.The investigators aimed to obtain safety and efficacy data for edoxaban in children.We performed a phase 3, multinational, prospective, randomized, open-label, blinded-endpoint trial in patients 18 years of age with cardiac disease (ENNOBLE-ATE [Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease] trial). Patients were randomized 2:1 to age- and weight-based oral edoxaban once daily vs SOC for 3 months (main study period), stratified by cardiac diagnosis. Both groups could continue in an open-label edoxaban extension arm through 1 year. The primary endpoint was adjudicated clinically relevant bleeding (CRB). The main secondary endpoint was symptomatic TE or asymptomatic intracardiac thrombosis.The modified intention-to-treat cohort included 167 children. One patient per group experienced a nonmajor CRB in the main period. Treatment-emergent adverse events occurred in 46.8% (51 of 109) with edoxaban and 41.4% (24 of 58) with SOC. One SOC patient experienced 2 TE events (DVT with PE). Among 147 children in the extension, 1 CRB event (0.7%) and 4 TEs occurred (2.8%; 2 strokes and 2 of 33 Kawasaki disease patients with coronary artery thromboses and/or myocardial infarctions).Edoxaban is a potential alternative mode of thromboprophylaxis in children with cardiac disease showing low rates of CRB and TEs with advantages of once daily dosing and infrequent monitoring requirement. (ENNOBLE-ATE [Edoxaban for Prevention of Blood Vessels Being Blocked by Clots] (Thrombotic Events) in Children at Risk Because of Cardiac Disease trial; NCT03395639).

Published
2022

5. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

Author

Portman, Michael A., primary, Jacobs, Jeffrey P., additional, Newburger, Jane W., additional, Berger, Felix, additional, Grosso, Michael A., additional, Duggal, Anil, additional, Tao, Ben, additional, Goldenberg, Neil A., additional, Brothers, Matthew, additional, Marino, Bradley, additional, Canter, Charles, additional, Law, Mark, additional, Nguyen, Nguyenvu, additional, Sang, Charlie, additional, Shimano, Kristin, additional, Gupta, Dipankar, additional, Portman, Michael, additional, Williams, Derek, additional, Glass, Lauren, additional, Sperrazza, Charles, additional, Herold, Steven, additional, Garg, Ruchira, additional, Vranicar, Mark, additional, Awad, Sawsan, additional, Asante-Korang, Alfred, additional, Druzgal, Colleen, additional, Ozment, Caroline, additional, Del Toro, Kamill, additional, Roses, Ferran, additional, Jux, Christian, additional, Gravenhorst, Verena, additional, Schweigmann, Ulrich, additional, Bhatt, Mihir, additional, Sabapathy, Christine, additional, Dahdah, Nagib, additional, Bartonicek, Dototea, additional, Tulzer, Gerald, additional, Basargina, Elena, additional, Zvereva, Tatiana, additional, Pertels, Tatiana, additional, Plotnikova, Irina, additional, Pierre-Emmanuel, S.E.G.U.E.L.A., additional, Amedro, Pascal, additional, Yves, Dulac, additional, BONNET, Damien, additional, Saraco, Paola, additional, Rimini, Alessandro, additional, Digtiar, Valerii, additional, Gonchar, Margaryta, additional, Kryuchko, Tetyana, additional, Yablon, Olga, additional, Bedi, Varinder Singh, additional, Patel, Jashvant, additional, Mitra, Monjori, additional, Kusa, Jacek, additional, Domagala, Kowalczyk, additional, KÖRNYEI, László, additional, BERECZKI, Csaba, additional, ABLONCZY, László, additional, Levitas, Vivianne Aviva, additional, Mishali, David, additional, Revel-Vilk, Shoshana, additional, Harlev, Dan, additional, Sasmaz, Hatice Ilgen, additional, Ozbek, Namik Yasar, additional, Unal, Sule, additional, Patıroglu, Türkan, additional, Malbora, Baris, additional, Agin, Hasan, additional, Karakas, Zeynep, additional, Kavakli, Ramazan Kaan, additional, Chalmers, Elizabeth, additional, Bu'Lock, Frances, additional, Daubeney, Piers, additional, Hamza, Hala, additional, Badr, Mohamed, additional, Elalfy, Mohsen, additional, Mansour, Ahmed, additional, Hassab, Hoda, additional, Sabry, Ayman, additional, Daou, Linda, additional, and Bitar, Fadi, additional

Published
2022
Full Text
View/download PDF

8. TCT-239 Efficacy and Safety of Short-Infusion Tirofiban in Patients Undergoing Percutaneous Coronary Intervention: The SAVI-PCI Trial

Author

Saucedo, Jorge, primary, Price, Matthew, additional, Berger, Peter, additional, Abu-Fadel, Mazen, additional, Jefferson, Brian, additional, Arcarese, Michael, additional, Matthai, Bill, additional, Picon, Hector, additional, Singh, Varinder, additional, Jaber, Wissam, additional, Sizemore, B. Clay, additional, McGarvey, Joseph, additional, Brown, Kyle, additional, Friesen, Albert, additional, and Manoukian, Steven, additional

Published
2021
Full Text
View/download PDF

9. Out-of-Hospital Cardiac Arrest and Acute Coronary Syndrome Hospitalizations During the COVID-19 Surge

Author

Moussa Saleh, Stavros E. Mountantonakis, Jeffrey T. Kuvin, Laurence M. Epstein, Michael Qiu, Lawrence Ong, Rajiv Jauhar, Varinder Singh, and Kristie M Coleman

Subjects
Acute coronary syndrome, medicine.medical_specialty, Emergency Medical Services, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, 030204 cardiovascular system & hematology, Out of hospital cardiac arrest, 03 medical and health sciences, Betacoronavirus, 0302 clinical medicine, Ambulatory care, Pandemic, medicine, Humans, In patient, 030212 general & internal medicine, Letters, Acute Coronary Syndrome, Pandemics, Retrospective Studies, business.industry, SARS-CoV-2, virus diseases, COVID-19, Retrospective cohort study, medicine.disease, Hospitalization, Pneumonia, Emergency medicine, Communicable Disease Control, New York City, business, Cardiology and Cardiovascular Medicine, Coronavirus Infections, Out-of-Hospital Cardiac Arrest
Abstract

The New York (NY) metropolitan area was the epicenter of the coronavirus disease-2019 (COVID-19) pandemic. Ambulatory care was dramatically curtailed, emergency departments (EDs) were overwhelmed, and patients were advised to stay home ([1][1]). A reduction in patients presenting with acute coronary

Published
2020

11. TWO-CENTRE ANALYSIS OF CARDIAC AMYLOIDOSIS PATIENTS IN CARDIOGENIC SHOCK REQUIRING TEMPORARY MECHANICAL CIRCULATORY SUPPORT

Author

Kumar, Salil, primary, Randhawa, Varinder, additional, Lee, Ran, additional, Ives, Lauren, additional, Soltesz, Edward G., additional, Tong, Michael Z.Y., additional, Starling, Randall C., additional, Hernandez-Montfort, Jaime, additional, Mazen, Hanna, additional, Trachtenberg, Barry, additional, and Estep, Jerry, additional

Published
2021
Full Text
View/download PDF

15. TCT-239 Efficacy and Safety of Short-Infusion Tirofiban in Patients Undergoing Percutaneous Coronary Intervention: The SAVI-PCI Trial

Author

Albert Friesen, Hector Picon, Jorge F. Saucedo, Peter B. Berger, Varinder Singh, Brian K. Jefferson, Mazen Abu-Fadel, Joseph McGarvey, Steven V. Manoukian, Matthew Price, B. Clay Sizemore, Bill Matthai, Kyle Brown, Michael Arcarese, and Wissam Jaber

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Internal medicine, Conventional PCI, Cardiology, medicine, Percutaneous coronary intervention, In patient, Tirofiban, Cardiology and Cardiovascular Medicine, business, medicine.drug
Published
2021

19. TELE-PHARMACY CARE OF GUIDELINE-DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS IS FEASIBLE DURING THE COVID-19 PANDEMIC

Author

Maria Mountis, Wai Hong Tang, Varinder Randhawa, Randall C. Starling, Bjoern Toennes, Daniel A. Lewis, Sanjeeb Bhattacharya, Luciane West, and Jerry D. Estep

Subjects
Spotlight on Special Topics, Coronavirus disease 2019 (COVID-19), business.industry, Heart failure, Pandemic, medicine, Pharmacy, Medical emergency, Guideline, Cardiology and Cardiovascular Medicine, medicine.disease, business, Medical therapy
Published
2021

20. INCREASED INPATIENT MORTALITY FOR CARDIOVASCULAR PATIENTS DURING THE FIRST WAVE OF THE COVID-19 EPIDEMIC IN NEW YORK

Author

Stavros E. Mountantonakis, Kristie M Coleman, Varinder Singh, Parth Makker, Moussa Saleh, Laurence M. Epstein, Jeffrey T. Kuvin, Rajiv Jauhar, and Gregg Husk

Subjects
Male, Time Factors, Arrhythmias, law.invention, Sudden cardiac death, Spotlight on Special Topics, law, Risk Factors, Arrhythmia and Electrophysiology, Myocardial infarction, Hospital Mortality, Young adult, Original Research, Aged, 80 and over, Quality and Outcomes, Incidence (epidemiology), COVID‐19 pandemic, Middle Aged, Health Services, Intensive care unit, Hospitalization, Cardiovascular Diseases, Female, Cardiology and Cardiovascular Medicine, Adult, Acute coronary syndrome, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Risk Assessment, sudden cardiac death, acute coronary syndrome, Young Adult, Percutaneous Coronary Intervention, Internal medicine, medicine, Diseases of the circulatory (Cardiovascular) system, Humans, Aged, Retrospective Studies, Inpatients, Inpatient mortality, business.industry, COVID-19, Retrospective cohort study, Odds ratio, medicine.disease, RC666-701, Emergency medicine, New York City, business
Abstract

Background The acuity and magnitude of the first wave of the COVID‐19 epidemic in New York mandated a drastic change in healthcare access and delivery of care. Methods and Results We retrospectively studied patients admitted with an acute cardiovascular syndrome as their principal diagnosis to 13 hospitals across Northwell Health during March 11 through May 26, 2020 (first COVID‐19 epidemic wave) and the same period in 2019. Three thousand sixteen patients (242 COVID‐19 positive) were admitted for an acute cardiovascular syndrome during the first COVID‐19 wave compared with 9422 patients 1 year prior (decrease of 68.0%, P P P P =0.033). Inpatient cardiovascular mortality during the first epidemic outbreak increased by 111.1% (3.8 versus 1.8, P P Conclusions A lower rate and later presentation of patients with cardiovascular pathology, coupled with deviation from common clinical practice mandated by the first wave of the COVID‐19 pandemic, might have accounted for higher in‐hospital cardiovascular mortality during that period.

Published
2021

21. TWO-CENTRE ANALYSIS OF CARDIAC AMYLOIDOSIS PATIENTS IN CARDIOGENIC SHOCK REQUIRING TEMPORARY MECHANICAL CIRCULATORY SUPPORT

Author

Ran Lee, Hanna Mazen, Jaime Hernandez-Montfort, Randall C. Starling, Barry H. Trachtenberg, Lauren Ives, Jerry D. Estep, Edward G. Soltesz, Michael Z.Y. Tong, Varinder Randhawa, and Salil Kumar

Subjects
medicine.medical_specialty, Cardiac amyloidosis, business.industry, Internal medicine, Cardiogenic shock, Circulatory system, medicine, Cardiology, Cardiology and Cardiovascular Medicine, medicine.disease, business
Published
2021

22. PRE-IMPLANT LEFT VENTRICULAR SIZE BEST PREDICTS POOR CARDIAC POWER INDEX IN PATIENTS WITH HM3 SUPPORT

Author

W.H. Wilson Tang, Randall C. Starling, Tiffany Buda, Varinder Randhawa, Qiuqing Wang, Michael Z.Y. Tong, Edward G. Soltesz, Katherine E. Wolski, Jerry D. Estep, and Shinya Unai

Subjects
medicine.medical_specialty, business.industry, Power index, Internal medicine, Left ventricular size, Cardiology, Medicine, In patient, Implant, Cardiology and Cardiovascular Medicine, business
Published
2020

23. INTER- AND INTRA-USER VARIABILITY OF THE SYNTAX SCORE

Author

Neil L. Coplan, Evan Levine, Shankar Thampi, Varinder Singh, Astha Tejpal, Umar Rashid, Craig Basman, and Ryan Barry

Subjects
Syntax (programming languages), business.industry, Medicine, Artificial intelligence, Cardiology and Cardiovascular Medicine, business, computer.software_genre, computer, Natural language processing
Published
2020

24. SHORT TERM READMISSIONS AFTER PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE NATIONWIDE READMISSION DATABASE OVER A PERIOD OF 5 YEARS

Author

Atti, Varunsiri, primary, Nalluri, Nikhil, additional, Tripathi, Byomesh, additional, Kumar, Varun, additional, Patel, Nileshkumar, additional, Mujer, Mark Terence, additional, Yandrapalli, Srikanth, additional, Venkata, Vikramaditya Samala, additional, Singh, Varinder, additional, and Kim, Michael, additional

Published
2019
Full Text
View/download PDF

25. IMPACT OF CLINICAL PRESENTATION ON THE DETECTION OF VULNERABLE PLAQUE BY NEAR INFRARED SPECTROSCOPY: A LIPID RICH PLAQUE (LRP) STUDY SUB-ANALYSIS

Author

Shlofmitz, Evan, primary, Craig, Paige, additional, Garcia, Hector Garcia, additional, Singh, Varinder, additional, Ali, Ziad, additional, Skinner, William, additional, Artis, Andre, additional, Cate, Tim Ten, additional, Wang, Rui, additional, Madden, Sean, additional, Shah, Priti, additional, Zou, Quan, additional, Muller, James, additional, Di Mario, Carlo, additional, Torguson, Rebecca, additional, and Waksman, Ron, additional

Published
2019
Full Text
View/download PDF

26. IMPACT OF CLINICAL PRESENTATION ON THE DETECTION OF VULNERABLE PLAQUE BY NEAR INFRARED SPECTROSCOPY: A LIPID RICH PLAQUE (LRP) STUDY SUB-ANALYSIS

Author

Varinder P. Singh, Ziad Ali, Sean P. Madden, Hector Garcia Garcia, Paige Craig, Rebecca Torguson, Priti Shah, Ron Waksman, James E. Muller, Tim ten Cate, Carlo Di Mario, William Skinner, Rui Wang, Andre Artis, Evan Shlofmitz, and Quan Zou

Subjects
Pathology, medicine.medical_specialty, business.industry, technology, industry, and agriculture, Context (language use), equipment and supplies, medicine.disease_cause, Vulnerable plaque, Medicine, lipids (amino acids, peptides, and proteins), cardiovascular diseases, Lipid-rich plaque, Cardiology and Cardiovascular Medicine, business, Mace
Abstract

Lipid rich plaque (LRP) can be detected by near infrared spectroscopy (NIRS) to predict vulnerable plaque, as shown in the LRP Study. The aim of this analysis was to assess the impact of clinical presentation on non-culprit MACE (NC-MACE) in the context of the detection of vulnerable plaque by NIRS

Published
2019

27. SHORT TERM READMISSIONS AFTER PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE NATIONWIDE READMISSION DATABASE OVER A PERIOD OF 5 YEARS

Author

Nikhil Nalluri, Nileshkumar J. Patel, Byomesh Tripathi, Varunsiri Atti, Mark Terence Mujer, Michael C. Kim, Varinder Singh, Srikanth Yandrapalli, Varun Kumar, and Vikramaditya Samala Venkata

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Emergency medicine, Medicine, Percutaneous coronary intervention, Cardiology and Cardiovascular Medicine, business, Period (music), Term (time)
Published
2019

28. TCT-108 Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

Author

Basman, Craig, primary, Hemli, Jonathan, additional, Kim, Michael, additional, Seetharam, Karthik, additional, Brinster, Derek, additional, Pirelli, Luigi, additional, Scheinerman, Jacob, additional, Singh, Varinder, additional, and Patel, Nirav C., additional

Published
2018
Full Text
View/download PDF

29. DOES MINIMALLY-INVASIVE BYPASS SURGERY AFFORD A LONG-TERM SURVIVAL ADVANTAGE COMPARED WITH DRUG-ELUTING STENT FOR ISOLATED COMPLEX DISEASE OF THE LEFT ANTERIOR DESCENDING CORONARY ARTERY?

Author

Patel, Nirav C., primary, Singh, Varinder P., additional, Seetharam, Karthik, additional, Hemli, Jonathan M., additional, Scheinerman, S. Jacob, additional, Pirelli, Luigi, additional, Brinster, Derek R., additional, Grines, Cindy L., additional, Kliger, Chad A., additional, Mihelis, Efstathia A., additional, and Kim, Michael C., additional

Published
2018
Full Text
View/download PDF

30. TCT-108 Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

Author

Luigi Pirelli, Jacob Scheinerman, Craig Basman, Derek R. Brinster, Jonathan M. Hemli, Michael C. Kim, Nirav C. Patel, Varinder P. Singh, and Karthik Seetharam

Subjects
Hybrid coronary revascularization, medicine.medical_specialty, Percutaneous, Left internal mammary artery, business.industry, medicine.medical_treatment, Coronary artery bypass surgery, surgical procedures, operative, Triple vessel disease, Surgical Graft, Internal medicine, Long term survival, cardiovascular system, medicine, Cardiology, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, human activities
Abstract

Hybrid coronary revascularization (HCR) combines a left internal mammary artery (LIMA) to left anterior descending (LAD) surgical graft, usually performed via a robotic-assisted, minimally-invasive approach, with drug-eluting stents placed in the remaining diseased non-LAD vessels. We sought to

Published
2018

31. DOES MINIMALLY-INVASIVE BYPASS SURGERY AFFORD A LONG-TERM SURVIVAL ADVANTAGE COMPARED WITH DRUG-ELUTING STENT FOR ISOLATED COMPLEX DISEASE OF THE LEFT ANTERIOR DESCENDING CORONARY ARTERY?

Author

Chad Kliger, Varinder P. Singh, Luigi Pirelli, Derek R. Brinster, S. Jacob Scheinerman, Jonathan M. Hemli, Cindy L. Grines, Karthik Seetharam, Efstathia Mihelis, Michael C. Kim, and Nirav C. Patel

Subjects
medicine.medical_specialty, Percutaneous, business.industry, medicine.medical_treatment, Complex disease, Anterior Descending Coronary Artery, surgical procedures, operative, medicine.anatomical_structure, Bypass surgery, Drug-eluting stent, Internal medicine, Conventional PCI, Long term survival, medicine, Cardiology, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, Artery
Abstract

No significant difference in long-term survival has, as yet, been identified for patients with isolated proximal lesions of the left anterior descending (LAD) coronary artery undergoing either robotic-assisted minimally-invasive coronary artery bypass (MIDCAB) or percutaneous intervention (PCI) with

Published
2018

32. HYPOTHERMIA VERSUS NORMOTHERMIA, AND OUTCOME DEPENDENCE ON TARGET TEMPERATURE, IN OUT-OF-HOSPITAL CARDIAC ARREST: A META-REGRESSION OF RANDOMIZED TRIALS

Author

Varinder Randhawa, Shahar Lavi, and Janet Martin

Subjects
medicine.medical_specialty, business.industry, Hypothermia, Outcome (game theory), Out of hospital cardiac arrest, law.invention, Randomized controlled trial, law, medicine, Meta-regression, medicine.symptom, Intensive care medicine, business, Cardiology and Cardiovascular Medicine
Abstract

Recent studies indicate that aggressive hypothermia for out-of-hospital cardiac arrest (OHCA) may be unnecessary. This has raised skepticism regarding the utility of hypothermia for OHCA. The aim of this meta-analysis was to determine whether hypothermia improves clinically-relevant outcomes

Published
2015
Full Text
View/download PDF

35. SAFETY AND EFFICACY OF BIORESORBABLE POLYMER FOR CORONARY ARTERY DISEASE: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIAL

Author

Rhanderson Cardoso, Carlos Alfonso, Mohammad Ansari, Babak Hassid, Varinder Singh, and Daniel Garcia

Subjects
medicine.medical_specialty, medicine.medical_treatment, Bioresorbable polymers, 0211 other engineering and technologies, 02 engineering and technology, urologic and male genital diseases, law.invention, Coronary artery disease, Randomized controlled trial, law, Internal medicine, 021105 building & construction, Coronary stent, medicine, business.industry, Stent, equipment and supplies, 021001 nanoscience & nanotechnology, medicine.disease, Surgery, Meta-analysis, Cardiology, 0210 nano-technology, Cardiology and Cardiovascular Medicine, business, hormones, hormone substitutes, and hormone antagonists
Abstract

Newer bioresorbable polymer (BPS) coronary stent has been developed to improve stent healing and increase endothelialization. We sought to compare the safety and efficacy of BPS to new-generation DES for treatment of ACS. We searched Pub Med and Cochrane trough October 2015 for all RCTs that

Published
2016

36. SAFETY AND EFFICACY OUTCOMES OF BIORESORBABLE SCAFFOLD STENTS FOR TREATMENT OF ISCHEMIC CORONARY ARTERY DISEASE: A META-ANALYSIS OF RCTS

Author

Carlos Alfonso, Rhanderson Cardoso, Varinder Singh, Babak Hassid, Daniel Garcia, and Mohammad Ansari

Subjects
Coronary artery disease, medicine.medical_specialty, business.industry, Internal medicine, Meta-analysis, Cardiology, Medicine, Cardiology and Cardiovascular Medicine, business, medicine.disease, Bioresorbable scaffold, Surgery
Published
2016

37. ENHANCED STENT IMAGING IMPROVES THE DIAGNOSIS OF STENT UNDEREXPANSION AND OPTIMIZES STENT DEPLOYMENT

Author

Giora Weisz, Gregg W. Stone, Gary S. Mintz, Jeffrey W. Moses, Akiko Maehara, Diaa Hakim, Roxana Mehran, Diana Wong, Ariel Hidalgo, LeRoy E. Rabbani, Elias Sanidas, Varinder Singh, Ravit Barkama, and Martin B. Leon

Subjects
medicine.medical_specialty, Stent deployment, business.industry, medicine.medical_treatment, medicine, Stent, Radiology, business, Cardiology and Cardiovascular Medicine
Published
2011
Full Text
View/download PDF

40. 1117-90 Establishing a new therapeutic activated partial thromboplastin time range for unfractionated heparin for acute coronary syndromes

Author

Venu Menon, Varinder Singh, James R. Wilentz, Judith S. Hochman, Michael S. Lee, and Joseph Schappert

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, Range (biology), Internal medicine, Cardiology, Medicine, Heparin, business, Cardiology and Cardiovascular Medicine, medicine.drug, Partial thromboplastin time
Published
2004
Full Text
View/download PDF

41. ENHANCED STENT IMAGING IMPROVES THE DIAGNOSIS OF STENT UNDEREXPANSION AND OPTIMIZES STENT DEPLOYMENT

Author

Sanidas, Elias, primary, Maehara, Akiko, additional, Barkama, Ravit, additional, Hidalgo, Ariel, additional, Hakim, Diaa, additional, Singh, Varinder, additional, Rabbani, LeRoy, additional, Mehran, Roxana, additional, Wong, Diana, additional, Mintz, Gary S., additional, Stone, Gregg W., additional, Leon, Martin B., additional, Moses, Jeffrey W., additional, and Weisz, Giora, additional

Published
2011
Full Text
View/download PDF

44. Diabetics achieve lower activated clotting time when given the same dose of heparin as nondiabetics during percutaneous coronary intervention

Author

Salvatore Rametta, Varinder Singh, James R. Wilentz, Tom Nero, Michael S. Lee, and Marshal Fox

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.medical_treatment, Internal medicine, medicine, Cardiology, Activated clotting time, Percutaneous coronary intervention, Heparin, Cardiology and Cardiovascular Medicine, business, medicine.drug
Published
2003

46. PRE-HOSPITAL VERSUS IN-HOSPITAL HYPOTHERMIA FOR OUT-OF-HOSPITAL CARDIAC ARREST: A META-ANALYSIS OF RANDOMIZED TRIALS

Author

Shahar Lavi, Janet Martin, and Varinder Randhawa

Subjects
medicine.medical_specialty, Randomized controlled trial, law, business.industry, Meta-analysis, Emergency medicine, medicine, Hypothermia, medicine.symptom, business, Cardiology and Cardiovascular Medicine, Out of hospital cardiac arrest, law.invention
Abstract

There remains controversy whether earlier initiation of hypothermia for patients with cardiac arrest improves outcomes. The aim of this study was to determine whether hypothermia initiated in the field (pre-hospital) improves clinically relevant outcomes compared with hypothermia initiated after

Full Text
View/download PDF

47. GRAYSCALE INTRAVASCULAR ULTRASOUND EVIDENCE OF IN-STENT NEOATHEROSCLEROSIS 3 YEARS AFTER DRUG-ELUTING STENT IMPLANTATION

Author

Varinder Singh, Diaa Hakim, Reni Rusinova, Akiko Maehara, Martin B. Leon, Jeffery W. Moses, Gregg W. Stone, Giora Weisz, and Gary S. Mintz

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.medical_treatment, Stent, equipment and supplies, surgical procedures, operative, Drug-eluting stent, Intravascular ultrasound, medicine, Radiology, cardiovascular diseases, business, Cardiology and Cardiovascular Medicine
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results